Abcellera Biologics Inc at Credit Suisse Healthcare Conference Transcript
© -
All right. So welcome, everyone, to the 31st Annual Healthcare Conference Credit Suisse. I'm Tiago Fauth. I'm a biotech analyst at Credit Suisse, joined today by AbCellera. We have Andrew Booth, CFO of the company, for a fireside chat. So an informal conversation about the company for the next 25 minutes or so. Nice to see you in person finally.
Finally, yes, a couple of years of working together.
© -
I always like to give you guys a couple of minutes to talk bigger picture about AbCellera business model, big picture things, and I'm going to have several detailed follow-ups after that. But yes, if you could talk -- it's a name that is a little bit unusual from a business model perspective. So I don't know if everyone is super familiar with it. So can you give us the 2
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |